comparemela.com

Latest Breaking News On - Academy professor seppo yl - Page 1 : comparemela.com

University of Helsinki: Finnish coronavirus vaccine developer Rokote Laboratories Finland secures significant funding

University of Helsinki: Finnish coronavirus vaccine developer Rokote Laboratories Finland secures significant funding
indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.

Researchers discover novel non-coding RNAs regulating blood vessel formation

 E-Mail Credit: UEF/ Raija Törrönen Researchers at the University of Eastern Finland have discovered previously unknown non-coding RNAs (ncRNAs) involved in regulating the gene expression of vascular endothelial growth factors (VEGF), the master regulators of angiogenesis. The study, conducted by the research groups of Associate Professor Minna Kaikkonen-Määttä and Academy Professor Seppo Ylä-Herttuala, provides a better understanding of the complex interplay of ncRNAs with gene regulation, which might open up novel therapeutic approaches in the future. The results were published in the Molecular and Cellular Biology Journal. Over the past years, the development of next generation sequencing techniques has revealed that around 97% of the human transcriptome is transcribed as non-coding RNAs, and although the role of the vast majority remains uncharacterized, many functions such as gene regulation have been proven.

Finnish academics developing intranasal COVID-19 vaccine

Credit: University of Eastern Finland Recently-formed Rokote Laboratories Finland is developing an intranasal vaccine against COVID-19 utilising specialised gene transfer technology. The company, which has emerged from University of Eastern Finland (UEF) and University of Helsinki (UHEL), is currently seeking investment to support the further development and marketisation of the vaccine, with human trials hoped to take place within the next few months. WHY IT MATTERS The gene transfer technology foundational to the vaccine is developed at UEF by Rokote’s own Academy Professor Seppo Ylä-Herttuala. A cloned DNA strand inside a safe adenovirus carrier incites the nasopharyngeal cells to make the SARS-CoV-2 virus protein, the virus that causes COVID-19. The vaccine does not carry any of the actual virus but rather triggers an immune response in the body.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.